From: Endoscopic thyroid surgery via a breast approach: a single institution’s experiences
Characteristics | Number | |
---|---|---|
Tumour size (cm) | 1.05 ± 0.79 | |
Tumour location | Right | 56 (43.8%) |
Left | 52 (40.6%) | |
Isthmus | 7 (5.5%) | |
Bilateral | 12 (9.4%) | |
Capsule invasion | 26 (21.3%) | |
Extrathyroidal extension | 6 (4.7%) | |
Lymphatic invasion | 22 (20.0%) | |
Multiplicity | 22 (17.2%) | |
Central lymph node metastasis | 76 (59.4%) | |
Retrieved central lymph nodes | 6.15 ± 4.90 (range 1-26) | |
Metastatic central lymph nodes | 3.53 ± 2.78 (range 1-16) | |
TNM stage | I | 106 (92.2%) |
II | 0 | |
III | 9 (7.8%) | |
Mean follow-up period (months) | 54.0 ± 35.7 (range 6-160) |